Professional Documents
Culture Documents
Al, Olama AA., K.-J. Z. (2009). Multiple loci on 8q24 associated with prostate
cancer susceptibility. Nat Genet , 1058-60.
Alberts, B., Johnson, A., Lewis. J., Morgan, D., Raff, M., Roberts, K. (2008).
Molecular Biology of The Cell. Garland Sciences.
American Cancer Society. (2015, August 6). Cancer Facts and Figures 2015.
Baretton, GB., Vogt, T., Blasenbreu, S., Lohrs, U. (1994). Comparison of DNA
ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the
prostate. An image cytometric study. Hum Pathol (25), 506-513.
Bhurgri, Y., Kayani, N., Pervez, S. (2001). Incidence and trends of prostate cancer
in karachi south, 1995-2002. Asian Pac J Cancer Prev (10), 45-8.
1
related to number of involved cores and morphologic pattern. Am J Surg
Pathol (28), 629-633.
Brawer, MK., Bigler, SA., Sohlberg, OE., Nagle, RB., Lange, PH. (1991).
Significance of prostatic intraepithelial neoplasia on prostate needle
biopsy. Urology (38), 103-107.
Christian, JD., Lamm, TC., Morrow, JF., Bostwick, DG. (2005). Corpora
amylacea in adenocarcinoma of the prostate: incidence and histology within
needle core biopsies. Mod Pathol (18), 36-39
2
Del, Rosario AD., Bui, HX., Abdulla, M., Ross, JS. (1993). Sulfur-rich prostatic
intraluminal crystalloids. A surgical pathologic and electron probe x-ray
microanalytic study. Hum Pathol (24), 1159-1167.
Fowler JE Jr, S. J. (2000). Percent free prostate speific antigen and cancer
detection in black and white men with total prostate specific antigen 2.5 to
9.9 ng/ml. J Urol (5), 1467-70.
Garcia, JJ.,AlAhmadie, HA., Gopalan, A., Tickoo, SK., Scardino, PT., Reuter, VE
., Fine, SW. (2008). Do prostatic transition zone tumors have a distinct
morphology?. Am J Surg Pathol (32), 1709-1714.
Guyton, A. C., & Hall, J. E. (2012). Bukur Ajar Fisiologi Kedokteran Guyton &
Hall Edisi 11 (pp. 1055-1061). (Irawati, D. Ramadhani, & et. al., Eds.)
Jakarta: EGC.
3
Highlights on Prostate Cancer from Urological and Oncological Congresses in
2007. (2007).
Isselbacher, K. J., Braunwald, E., Wilson, J. D., Martin, J. B., Fauci, A. S. (2014).
Prinsip-Prinsip Ilmu Penyakit Dalam Harrison (pp. 2070-2071). (A. H.
Asdie, Ed.) Jakarta: EGC.
Jennifer, R. S. (2009). Gleason Score and Lethal Prostate Cancer : Does 3+4 =
4+3? Journal of clinical Oncology , 27 (21).
Jeong, IG., Kim, CS., Ro, JY. (2012). Introduction and prostate cancer statistic.
Advances in Surgical Pathology Prostate Cancer, 3-7.
Kang, DI., Chung, JI., Ha, HK. (2013). Korean prostate cancer patients have
worse disease characteristics than their american counterparts. Asian Pac J
Cancer Prev (14), 6913-7.
4
King, R. J. (2012). Cancer Biology Ed. 2. London School of Biological Sciences,
University of Surrey.
Klein, EA., Platz, EA., Thompson, IM. (2007). Epidemiology, etiology, and
prevention of prostate cancer. WEIN AJ,Kovoussi LR, Novick A, Partin AW,
Peters CA. Ed. Campbell-Walsh Urology. Philadelphia:Saunders, 2854-73.
Kumar, V., Cotran, R. S., & Robbins, S.L. (2013). Buku Ajar Patologi Robbins
(pp. 200-201, 746-748). Jakarta: EGC.
Mai, KT., Collins, JP., Veinot, JP. (2002). Prostatic adenocarcinoma with
urothelial (transitional cell) carcinoma features. Appl Immunohistochem Mol
Morphol (10), 231-236.
Mescher, K. L., Dalley, A. L., & Agur, A. M. (2012). Teks dan Atlas Histologi
Dasar Junqueira Edisi 12 (pp. 374-376). Jakarta: EGC.
Mottet, N., Shatken, JA., Heidenreich, A., Bastian, PJ., Irani, J. (2008). Highlights
on Prostate Cancer from Urological and Oncological Congresses in 2007. Eur
Urol Suppl, 460-73.
Nath, A., Singh, JK., Vendan, SE. (2012). Elevated level of prostate specific
antigen among prostat cancer patients and high prevalence in the gangetic
zone of bihar, India.Asian Pac J Cancer Prev (14), 63-8.
Nelles, J. L., Hu, W.-Y., & Prins, G. S. (2011). Estrogen action and prostate
cancer. Expert Rev Endocrinol Metab , 6 (3), 437-451.
5
Nurse, P. (2000). A Long Twentieth Century of The Cell Cycle and Beyond. Cell
(100), 71-78.
Pan, CC., Chiang, H., Chang, YH., Epstein, JI. (2000). Tubulocystic clear cell
adenocarcinoma arising within the prostate. Am J Surg Pathol (24), 1433-
1436.
Parwani, AV., Kronz, JD., Genega, EM., Gaudin, P., Chang, S. (2004). Prostate
carcinoma with squamous differentiation: an analysis of 33 cases. Am J Surg
Pathol (28), 651-657
Risbridger, G. P., Ellem, S. J., & McPherson, S. J. (2007). Estrogen action on the
prostate gland : a crtical mix of endocrine and paracrine signaling. Journal of
Molecular Endrocrinology (39), 183-188.
Ro, JY., Grignon, DJ., Ayala, AG., Fernandez, PL., Ordonéz, NG. (1990).
Mucinous adenocarcinoma of the prostate. Histochemical and
immunohistochemical studies. Hum Pathol (21), 593-600.
Ro, JY, MD., El-Naggar., Adel, MD., Ayala, Alberto G, MD. (1988). Signet-
Ring-Cell Carcinoma of The Prostate: Electron Microscopic and
6
Immunohistochemical Studies of Eight Cases. The American Journal of
Surgical Pathology.
Rosai, Juan. M. (2011). Rosai and Ackerman's Surgical Pathology Tenth Edition
(pp.1295-1303). Milan, Italy: Elsevier.
Ruddon, RW. (2007). Cancer Biology. New York : Oxford University Press.
Seisen, T., Roupret, M., Faix, A. (2012). The prostate gland: a crossroad between
the urinary and the seminal tracts. Prog Urol (22), 66-80.
Sjamsuhidajat, R., & Jong, W. D. (2014). Buku Ajar Ilmu Bedah (pp. 903-905).
Jakarta: EGC.
Totten, RS., Heinemann, MW., Hudson, PB., Sproul, EE., Stout, AP. (1953).
Microscopic differential diagnosis of latent carcinoma of the prostate. Arch
Pathol (55), 131-141.
Varma, M., Lee, MW., Tamboli, P., Zarbo, RJ., Jimerez, RE. (2002)
Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle
biopsy specimens: a study of 250 consecutive cases in a routine surgical
pathology practice. Arch Pathol Lab Med (126), 554-561.
7
Vinjamoori, A., Jagannathan, J., Shinagere, A. (2012). Atypica metastases from
prostate cancer: 10-year experience at a single institution. AJR. Am J
Roentgenol (199), 367-72.
WHO World Health Organization. (2010). Prostate cancer in Asia. World Health
Organization Medical Centre. http://www.who.int/ diakses pada 27 Maret
2016.
Yang, XJ., McEntee, M., Epstein, JI. (1998). Distinction of basaloid carcinoma of
the prostate from benign basal cell lesions by using immunohistochemistry
for bcl-2 and Ki-67. Hum Pathol (29), 1447-1450.
8
9